Liberia to try untested Ebola drug

Liberia will soon receive doses of an experimental Ebola drug and give it to two sick doctors, making them the first Africans to receive some of the scarce treatment in a spiralling outbreak.

The US government has put Liberian officials in touch with the California-based maker of ZMapp, Mapp Biopharmaceutical. The company said that in responding to a request from an unidentified West African country, it had run out of its supply of the treatment.